Short communication · 2015
EditorialPublished 20 Jul 2021
Cell-Derived Neurons or the Cell Replacement
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Neurodegenerative infections are named for the age-related constant and reformist loss of design and capacity of neurons. Most normal neurodegenerative infections incorporate Alzheimer's Disease (AD) and Parkinson's Disease (PD). Up until this point, no medications can be utilized to turn around the neuronal degeneration. Late advances in undeveloped cells science and innovation permit us to create explicit sorts of neurons, for example, cholinergic and dopamine neurons from undeveloped cells, with characterized culture conditions. These undifferentiated organism determined neurons have been utilized for cell substitution treatment in creature models of neurodegenerative neurons, like AD and PD. Here, I summed up late advances of immature microorganism inferred cholinergic and dopamine neurons and their applications in AD and PD.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 5 Jun 2013
Stem Cell-Derived Neurons for the Treatment of Neurodegenerative Diseases
Article · 5 Apr 2024
Mechanism of Linagliptin on Stromal Cell-Derived Factor 1 and Vascular Endothelial Growth Factor Protein after Molar Pulp Revascularization in Rats
Article · 20 Feb 2024
Targeted Regulating of TGFBR1 Expression by Bone Marrow Mesenchymal Stem Cell-Derived Exosome Let-7a and its Mechanism in Diabetic Nephropathy Rats
Review article · 23 Aug 2022
Induced Pluripotent Stem Cell-derived Cardiomyocytes can serve as Acellular Models for Cardiac Toxicity Testing
More from this journal
The newest in Journal of In Silico & In Vitro Pharmacology.
Short communication · 31 Mar 2025
Predictive Pharmacology in Action: Combining Molecular modelling and Laboratory Validation for Efficient Drug Development
Perspective · 31 Mar 2025
From Virtual Screening to Biological Validation: Integrating In Silico and In Vitro Strategies for Predictive Pharmacology
Opinion · 31 Mar 2025
Computational and Experimental Synergy: A Dual Approach to Pharmacological Profiling
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of In Silico & In Vitro Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sophia Collins”

